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Dear Sirs,
We read with interest the paper by Ho et al,1 which used the
AMSTAR tool to assess the methodological quality of systematic
reviews (SRs) on chronic obstructive pulmonary disease (COPD).
As staff at the Cochrane Airways Group with the responsibility of
producing high-quality SRs for airway conditions, including COPD,
we are always happy to hear how we could improve.
However, there are some methodological issues within the
study. The abstract states that the methodological quality of the
reviews was disappointing and emphasises the more negative
ﬁndings, neglecting the positive results (e.g., a priori design in 67%
SRs, comprehensive literature search in 97% and scientiﬁc quality
assessed and documented in 85%). The authors did not complete
the AMSTAR ratings in duplicate; yet, duplicate data extraction is a
mark of a good SR. Our experience with this tool is that the
discussion between two or more people helps reach a fair
judgement.2 It would have been helpful to see the AMSTAR
ratings per review so that the work could be replicated and
evaluated.
We noted the lack of discussion about the choice to limit the
study to SRs that include a meta-analysis. Choosing not to perform
a meta-analysis when there is a lot of heterogeneity between
studies is a valid decision.
The authors highlighted that non-English databases were
searched infrequently. This is not an AMSTAR criterion; have the
authors suggested that this be incorporated in any update of the
tool? Cochrane does not require that non-English language
databases be searched and this is usually done only when we
expect that this will yield additional relevant trials. We agree that
multilingual SR teams are advantageous and we would be grateful
if people who wish to translate the trial reports for inclusion in
Cochrane reviews contact us.
We take the authors’ point about being clearer about reviewers’
support, and making a statement about publication bias in the
results section as well as the methods section when there are too
few studies to permit a funnel plot.
As highlighted in the paper, the quality of SRs has improved
signiﬁcantly in recent years through the development of
methods and improved implementation.3,4 It would have been
helpful to highlight this important point in the conclusions and
abstract.
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